Enorama Pharma AB (publ) (STO: ERMA)

Enorama Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	41.75	47.53	46.41	64.1	76.26	73.68
Cash & Short-Term Investments	41.75	47.53	46.41	64.1	76.26	73.68
Cash Growth	-44.77%	2.43%	-27.61%	-15.94%	3.50%	-7.38%
Accounts Receivable	19.9	19.17	11.48	24.03	12.93	29.28
Other Receivables	6.67	3.5	3.64	1.92	2.44	3.59
Receivables	26.57	22.67	15.12	25.95	15.38	32.87
Inventory	0.29	0.36	0.31	0.55	1.05	-
Prepaid Expenses	-	2.9	3.4	3.51	3.68	1.88
Other Current Assets	-0	-0	-	-	-	-
Total Current Assets	68.6	73.47	65.23	94.11	96.37	108.42
Property, Plant & Equipment	10.41	6.45	9.09	11.47	8.92	1.89
Goodwill	-	84.84	84.84	84.84	23.43	23.43
Other Intangible Assets	128.62	21.83	24.26	26.72	4.59	5.4
Long-Term Deferred Tax Assets	-	-	-	-	-	5.75
Long-Term Deferred Charges	-	26.08	29.8	23.93	19.65	13.59
Other Long-Term Assets	-	-0	-	-	-	-
Total Assets	207.64	212.67	213.22	241.05	152.95	158.47
Accounts Payable	-	2.72	5.95	10.08	5.68	4.86
Accrued Expenses	-	8.45	5.08	26.55	12.28	12.82
Current Portion of Leases	-	8.47	11.74	1.67	1.13	1
Current Unearned Revenue	-	13.95	17.07	-	12.96	13.02
Other Current Liabilities	34.81	2.31	1.73	34.24	1.19	0.18
Total Current Liabilities	34.81	35.89	41.57	72.54	33.24	31.88
Long-Term Leases	21.9	13.46	20.99	5.93	5.67	0.07
Long-Term Deferred Tax Liabilities	-	4	4.36	5.62	-	-
Other Long-Term Liabilities	-	-0	-	28.92	-	0.05
Total Liabilities	56.71	53.35	66.92	113	38.91	32.01
Common Stock	150.93	23.54	14.25	11.88	10.81	10.81
Additional Paid-In Capital	-	917.82	887.56	849.4	823.19	823.19
Retained Earnings	-	-786.45	-760.05	-737.49	-724.05	-711.81
Comprensive Income & Other	-	4.41	4.53	4.27	4.1	4.28
Shareholders' Equity	150.93	159.32	146.3	128.05	114.04	126.47
Total Liabilities & Equity	207.64	212.67	213.22	241.05	152.95	158.47
Total Debt	21.9	21.93	32.73	7.6	6.8	1.07
Net Cash (Debt)	19.84	25.61	13.68	56.51	69.46	72.61
Net Cash Growth	-61.09%	87.19%	-75.79%	-18.65%	-4.33%	-8.72%
Net Cash Per Share	0.30	0.39	0.33	1.56	1.93	2.01
Filing Date Shares Outstanding	77.38	77.38	46.43	39.6	36.02	36.02
Total Common Shares Outstanding	77.38	77.38	46.43	39.6	36.02	36.02
Working Capital	33.8	37.58	23.66	21.57	63.13	76.54
Book Value Per Share	1.95	2.06	3.15	3.23	3.17	3.51
Tangible Book Value	22.31	52.65	37.21	16.5	86.03	97.64
Tangible Book Value Per Share	0.29	0.68	0.80	0.42	2.39	2.71
Machinery	-	7.24	7.12	6.18	2.63	1.72

Source: S&P Capital IQ. Standard template. Financial Sources.